Biosynex S.A. logo

Biosynex S.A. (FR0011005933)

Market Closed
7 Aug, 20:00
XSTU XSTU
0. 90
+0
+0.2237%
- Market Cap
- P/E Ratio
6.67% Div Yield
1,278 Volume
- Eps
0.89
Previous Close
Add Transaction
Day Range
0.89 0.9
Year Range
0.46 1.51
Want to track FR0011005933 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

FR0011005933 closed Friday higher at €0.9, an increase of 0.2237% from Thursday's close, completing a monthly increase of 0.9009% or €0.01. Over the past 12 months, FR0011005933 stock gained 54.4828%.
FR0011005933 is not paying dividends to its shareholders.
The last earnings report, released on Oct 19, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

FR0011005933 Chart

Biosynex S.A. (FR0011005933) FAQ

What is the stock price today?

The current price is €0.90.

On which exchange is it traded?

Biosynex S.A. is listed on XSTU.

What is its stock symbol?

The ticker symbol is FR0011005933.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 6.67%.

What is its market cap?

As of today, no market cap data is available.

Has Biosynex S.A. ever had a stock split?

No, there has never been a stock split.

Biosynex S.A. Profile

Health Care Technology Industry
Healthcare Sector
Mr. Larry Abensur CEO
XSTU Exchange
FR0011005933 ISIN
France Country
454 Employees
16 May 2022 Last Dividend
- Last Split
- IPO Date

Overview

Biosynex SA is a dynamic entity in the medical diagnostics industry, dedicated to the design, manufacture, and distribution of rapid diagnostic tests both in its home country of France and on an international scale. The company specializes in providing a comprehensive range of medical devices aimed at in vitro diagnosis, covering various essential fields such as bacteriology, parasitology, mycology, virology, biochemistry, oncology, and women's health. Recognized for its significant contributions during the COVID-19 pandemic, Biosynex SA adapted swiftly to global needs by offering specialized tests and instruments to combat the virus. Founded in 1993 and headquartered in Illkirch-Graffenstaden, France, Biosynex SA has established itself as a trusted partner in healthcare, catering to the needs of biology and medical analysis laboratories, hospitals, pharmacies, and even consumer markets such as hyper and supermarkets. The company's commitment to enhancing healthcare outcomes is further emphasized through its extensive international export activities, underscoring its global impact and ambition.

Products and Services

  • Rapid Diagnostic Tests, Immunoblots, Molecular Biology, and Point of Care Products

    These products are designed for efficient screening, diagnosis, and prevention in critical health areas including bacteriology, parasitology, mycology, virology, biochemistry, oncology, and women’s health. Biosynex SA leverages sophisticated technologies to offer rapid and reliable results, supporting medical professionals in making informed decisions swiftly.

  • COVID-19 Tests and Instruments

    In response to the global pandemic, Biosynex SA expanded its product range to include COVID-19 diagnostic tools. These include rapid tests for swift identification of the virus, as well as various instruments essential for testing procedures. The company’s agile adaptation to the pandemic underscores its commitment to public health and safety.

  • Self-tests and Self-measurement Products

    Understanding the growing demand for personal health monitoring, Biosynex SA offers a range of self-tests and self-measurement products. These include thermometers, oximeters, and blood pressure monitors, facilitating individuals to monitor their health conveniently and accurately from the comfort of their homes.

  • Oral Care and Medical Aid Products

    Beyond diagnostic solutions, Biosynex SA addresses broader healthcare needs by providing oral care and various medical aid products. These offerings underline the company’s commitment to comprehensive health and well-being, catering to both medical institutions and individual consumers.

Contact Information

Address: 22 Boulevard SEbastien Brant
Phone: 33 3 88 78 78 87